US FDA approves Gilead's twice-yearly injection for HIV prevention

U

US FDA approves Gilead's twice-yearly injection for HIV prevention The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly...